E-LIB Suche - Ergebnisse für: Badros, Ashraf

1

Post hoc analysis of daratumumab plus lenalidomide, bortezo..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
British Journal of Haematology. 204 (2024) 6 - p. 2227-2232 , 2024

Link: https://doi.org/10.1111/..

2

Single‐agent belantamab mafodotin in patients with relapsed..:

Nooka, Ajay K. ; Cohen, Adam D. ; Lee, Hans C....
Cancer. 129 (2023) 23 - p. 3746-3760 , 2023

Link: https://doi.org/10.1002/..

3

Immune-mediated facial nerve paralysis in a myeloma patient..:

Kathari, Yamini K. ; Ahmad, Haroon ; Kallen, Michael E....
Haematologica. 109 (2023) 2 - p. 682-688 , 2023

Link: https://doi.org/10.3324/..

4

Daratumumab plus lenalidomide/bortezomib/dexamethasone in B..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
Blood Cancer Journal. 12 (2022) 4 - p. , 2022

Link: https://doi.org/10.1038/..

5

A Plain Language Summary of Daratumumab Plus Lenalidomide/B..:

Nooka, Ajay K ; Kaufman, Jonathan L ; Rodriguez, Cesar...
Future Oncology. 18 (2022) 40 - p. 4443-4456 , 2022

Link: https://doi.org/10.2217/..

6

P-219: Daratumumab (DARA) + lenalidomide/bortezomib/dexamet..:

Nooka, Ajay ; Kaufman, Jonathan ; Rodriguez, Cesar...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S155-S156 , 2022

Link: https://doi.org/10.1016/..

7

Longer term outcomes with single‐agent belantamab mafodotin..:

Lonial, Sagar ; Lee, Hans C. ; Badros, Ashraf...
Cancer. 127 (2021) 22 - p. 4198-4212 , 2021

Link: https://doi.org/10.1002/..

8

MM-103: Relationship Between Corneal Exam Findings, Best-Co..:

Terpos, Evangelos ; Badros, Ashraf ; Popat, Rakesh...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S421 , 2021

Link: https://doi.org/10.1016/..

9

Poster: MM-103: Relationship Between Corneal Exam Findings,..:

Terpos, Evangelos ; Badros, Ashraf ; Popat, Rakesh...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S251 , 2021

Link: https://doi.org/10.1016/..

10

Expert review on soft‐tissue plasmacytomas in multiple myel..:

Rosiñol, Laura ; Beksac, Meral ; Zamagni, Elena...
British Journal of Haematology. 194 (2021) 3 - p. 496-507 , 2021

Link: https://doi.org/10.1111/..

11

Primary plasma cell leukemia: consensus definition by the I..:

Fernández de Larrea, Carlos ; Kyle, Robert ; Rosiñol, Laura...
Blood Cancer Journal. 11 (2021) 12 - p. , 2021

Link: https://doi.org/10.1038/..

12

Selinexor, bortezomib, and dexamethasone versus bortezomib ..:

Richard, Shambavi ; Chari, Ajai ; Delimpasi, Sosana...
American Journal of Hematology. 96 (2021) 9 - p. 1120-1130 , 2021

Link: https://doi.org/10.1002/..

13

Effect of age and frailty on the efficacy and tolerability ..:

Auner, Holger W. ; Gavriatopoulou, Maria ; Delimpasi, Sosana...
American Journal of Hematology. 96 (2021) 6 - p. 708-718 , 2021

Link: https://doi.org/10.1002/..

14

MM-219: Pivotal DREAMM-2 Study: Single-Agent Belantamab Maf..:

Lonial, Sagar ; Lee, Hans Chulhee ; Badros, Ashraf...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S301-S302 , 2020

Link: https://doi.org/10.1016/..

15

Biologic Implications of t(11;14) in Multiple Myeloma Expla..:

Soleimani, Arshia ; Koka, Madhurima ; Singh, Zeba N...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) 9 - p. e556-e559 , 2020

Link: https://doi.org/10.1016/..